Four‐year entecavir therapy reduces hepatocellular carcinoma, cirrhotic events and mortality in chronic hepatitis B patientsTung‐Hung Su, Jia‐Horng Kao, Ming‐Jong Bair et al.|Liver International|2016Cited by 221
Long-term changes of gut microbiota, antibiotic resistance, and metabolic parameters after Helicobacter pylori eradication: a multicentre, open-label, randomised trialJyh‐Ming Liou, Ming‐Shiang Wu, Emad El‐Omar et al.|The Lancet Infectious Diseases|2019Cited by 206
Concomitant, bismuth quadruple, and 14-day triple therapy in the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trialJyh‐Ming Liou, Ming‐Shiang Wu, Emad El‐Omar et al.|The Lancet|2016Cited by 202